ProCE Banner Activity

Answers to Frequently Asked Questions on the Rapidly Evolving Landscape in the Management of Patients With Advanced Endometrial Cancer

Clinical Thought

Expert commentary with answers to frequently asked questions posed during a live webinar following the 2024 Society of Gynecologic Oncology Annual Meeting, including experts’ thoughts and strategies on integrating new clinical trial data into treatment of advanced dMMR and pMMR endometrial cancer and the potential for new FDA approvals.

Released: June 12, 2024

Expiration: June 11, 2025

Share

Faculty

Ramez N. Eskander

Ramez N. Eskander, MD

Clinical Professor of Gynecologic Oncology
Clinical Trials Office Director for Oncology at UC San Diego Health and Moores Cancer Center
Co-Director, UC San Diego Health International Patient Program
Fellowship Director, Gynecologic Oncology
Member of the GOG Foundation
Associate Clinical Trial Advisor, GOG Partners
San Diego, California

Shannon N. Westin

Shannon N. Westin, MD, MPH, FASCO

Professor
Medical Director, Gynecologic
Oncology Center
Division of Surgery
Department of Gynecologic Oncology and Reproductive Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from GlaxoSmithKline.

GlaxoSmithKline

Disclosure

Primary Author

Ramez N. Eskander, MD

Clinical Professor of Gynecologic Oncology
Clinical Trials Office Director for Oncology at UC San Diego Health and Moores Cancer Center
Co-Director, UC San Diego Health International Patient Program
Fellowship Director, Gynecologic Oncology
Member of the GOG Foundation
Associate Clinical Trial Advisor, GOG Partners
San Diego, California

Ramez N. Eskander, MD: consultant/advisor/speaker: AstraZeneca, Caris, Clovis Oncology, Daiichi Sankyo, Eisai, GlaxoSmithKline, ImmunoGen, Merck/MSD, Mersana, Myriad, Nuvectis, PMV, Regeneron, Seagen.

Shannon N. Westin, MD, MPH, FASCO

Professor
Medical Director, Gynecologic
Oncology Center
Division of Surgery
Department of Gynecologic Oncology and Reproductive Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

Shannon N. Westin, MD, MPH, FASCO: researcher: AstraZeneca, Avenge Bio, Bayer, BioPath, Clovis/Pharma&, GlaxoSmithKline, Jazz Pharmaceuticals, Mereo, Novartis, Nuvectis, Roche/Genentech, Zentalis; consultant/advisor/speaker: AstraZeneca, Caris, Clovis/Pharma&, Eisai, EQRx, Gilead, GlaxoSmithKline, Immunocore, ImmunoGen, Lilly, Loxo, Mereo, Mersana, NGM Bio, Nuvectis, Roche/Genentech, Seagen, Verastem, Vincerx, Zentalis, ZielBio.